e-learning
resources
Paris 2018
Sunday, 16.09.2018
Organoids and pluripotent stem cells
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The potential of epigenetic editing in chronic lung disease
M. Rots (Groningen, Netherlands)
Source:
International Congress 2018 – Organoids and pluripotent stem cells
Session:
Organoids and pluripotent stem cells
Session type:
Symposium
Number:
278
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Rots (Groningen, Netherlands). The potential of epigenetic editing in chronic lung disease. International Congress 2018 – Organoids and pluripotent stem cells
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: ERS Lung Science Conference 2017
Year: 2017
DNA methylation and gene expression changes in human lung fibroblasts occur already in mild COPD and progress with disease development
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
The environment, epigenetics and lung disease
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013
Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020
Nutritional modulation to correct metabolic alterations in chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019
Transcriptomic and epigenetic changes in the lung of patients with severe COPD
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020
The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
Possible mechanisms underlying the development of cachexia in COPD
Source: Eur Respir J 2008; 31: 492-501
Year: 2008
COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011
Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Dissecting chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
LSC Abstract – microRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Post-viral effects on the susceptibility of developing chronic lung diseases
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021
Prediction of chronic lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 139s
Year: 2003
Subsequent COPD and lung cancer in patients with autoimmune disease
Source: Eur Respir J 2011; 37: 463
Year: 2011
LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept